1. TLR4 is one of the receptors for Chikungunya virus envelope protein E2 and regulates virus induced pro-inflammatory responses in host macrophages
   Chandan Mahish et al, 2023, Frontiers in Immunology CrossRef
2. Role of Metastasis-Related Genes in Cisplatin Chemoresistance in Gastric Cancer
   Yukiko Nishiguchi et al, 2019, International Journal of Molecular Sciences CrossRef
3. The Cancer Prevention, Anti-Inflammatory and Anti-Oxidation of Bioactive Phytochemicals Targeting the TLR4 Signaling Pathway
   Chung-Yi Chen et al, 2018, International Journal of Molecular Sciences CrossRef
4. Phosphorylation of OGFOD1 by Cell Cycle-Dependent Kinase 7/9 Enhances the Transcriptional Activity of RNA Polymerase II in Breast Cancer Cells
   Han-Teo Lee et al, 2021, Cancers CrossRef
5. Neutrophil Extracellular Trapping Role in Cancer, Metastases, and Cancer-Related Thrombosis: a Narrative Review of the Current Evidence Base
   Catalin I. Efrimescu et al, 2021, Current Oncology Reports CrossRef
6. Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
   Mariya Farooq et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
7. Platelet Toll-like Receptor 4–Related Innate Immunity Potentially Participates in Transfusion Reactions Independent of ABO Compatibility: An Ex Vivo Study
   Chien-Sung Tsai et al, 2021, Biomedicines CrossRef
8. Prognostic Value of NLRP3 Inflammasome and TLR4 Expression in Breast Cancer Patients
   Concetta Saponaro et al, 2021, Frontiers in Oncology CrossRef
9. Understanding and harnessing triple-negative breast cancer-related microbiota in oncology
   Ciaran Devoy et al, 2022, Frontiers in Oncology CrossRef
10. Bruton’s tyrosine kinase inhibitors in the treatment of primary central nervous system lymphoma: A mini-review
    Jing Shen et al, 2022, Frontiers in Oncology CrossRef
11. The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer
    Arianna Giacomini et al, 2023, Experimental Hematology & Oncology CrossRef
12. Aberrant Expression of TLR2, TLR7, TLR9, Splicing Variants of TLR4 and MYD88 in Chronic Lymphocytic Leukemia Patients
    Katarzyna Skorka et al, 2021, Journal of Clinical Medicine CrossRef
13. ERα36–GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells
    George Notas et al, 2021, International Journal of Molecular Sciences CrossRef
14. A novel immunogenic cell death signature for the prediction of prognosis and therapies in glioma
    Jianhua Zhang et al, 2023, PeerJ CrossRef
15. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
    Suprabhat Mukherjee et al, 2023, Frontiers in Immunology CrossRef
16. MyD88 signaling pathways: role in breast cancer
    Hongmei Zheng et al, 2024, Frontiers in Oncology CrossRef
17. Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation
    Xiong Zou et al, 2022, Frontiers in Molecular Biosciences CrossRef
18. Cytosolic Phospholipase A2 Alpha Regulates TLR Signaling and Migration in Metastatic 4T1 Cells
    Hanna Maja Tunset et al, 2019, International Journal of Molecular Sciences CrossRef